Checked.be
Active
BE 1000.994.171Private limited company
GPHARMA
Grand Route(PLX) 33 ·4122 Neupré, Belgium· 2 yrs active
Sector: Retail sale of pharmaceutical products
(47730)
Conclusion
The computed 12-month bankruptcy probability of GPHARMA is 2.2% (moderate). The 2024 annual accounts show equity of €171k and a net result of €71k. Its solvency ranks better than 38% of 873 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 1 annual account.
Key figures
| Equity | €171k |
| Net result | €71k |
| Better than sector | 38% |
| Active | 2 yrs |
Financial profile
52
/ 100
Mixed profile: strong on profitability, weaker on solvency.
Computed on 4 of 5 axes. Not measured: growth. An unmeasured axis is not a zero: no data was read for it.
Health
35
Profitability
100
Solvency
7
Growth
-
Stability
67
Bankruptcy probability (12 mo)
Risk Assessment
0 / 100
Low riskTrust signals
Young company
Founded in 2023, under 3 years, statistically higher risk.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Checked score
35
/ 100
Weak
Computed from 3 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Indicative credit limit
€6k
estimate, not credit advice
Score components
Liquidity
Current ratio 0.28 (< 1.0)
-10
Quick ratio
Quick ratio 0.28 (< 0.6)
-5
Leverage
Debt/equity 8.73 (> 3.0)
-10
Profitability
ROE 41% (≥ 10%)
+10
Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.
Financial overview
Annual accounts filed on 25-07-2025 with the NBB · fiscal year 2024 · full schema
Sector comparison
Fiscal year 2024 · NACE 47, Retail trade · compared within the same schema type (full schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 10.3% | 17.2% | |
| Net result | €71k | €14k | |
| Equity | €171k | €99k | |
| Gross operating margin | €92k | €213k | |
| Total assets | €1.66M | €750k |
Figures by fiscal year and ratios
| Fiscal year | 2024 |
|---|---|
| Deposit | full schema |
| Revenue | - |
| EBITDA | - |
| Net profit | €71k |
| Cash flow | - |
| Staff costs | - |
| Income taxes | €18k |
| Dividends | - |
| Total assets | €1.66M |
| Equity | €171k |
| Debt | €1.49M |
| of which ≤ 1y | €388k |
| of which > 1y | €1.10M |
| Working capital | €-278k |
| Employees (FTE) | - |
Ratios (computed)
| 2024 | |
|---|---|
| Current ratio | 0.28 |
| Quick ratio | 0.28 |
| Working capital ratio | -16.7% |
| Solvency | 10.3% |
| Debt / equity | 8.73 |
| Long-term debt ratio | 6.45 |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | 4.3% |
| ROE | 41.4% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Balance-sheet composition 2024
Full annual accounts (21 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €1.66M |
| Fixed assets | 21/28 | €1.55M |
| Financial fixed assets | 28 | €1.55M |
| Current assets | 29/58 | €110k |
| Amounts receivable within one year | 40/41 | €6 |
| Cash & bank | 54/58 | €110k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.66M |
| Equity | 10/15 | €171k |
| Contributions / capital | 10/11 | €100k |
| Accumulated profits (losses) | 14 | €71k |
| Amounts payable | 17/49 | €1.49M |
| Amounts payable after one year | 17 | €1.10M |
| Amounts payable within one year | 42/48 | €388k |
| Trade debts payable within one year | 44 | €0 |
| Income statement | ||
| Gross operating margin | 9900 | €92k |
| Operating result | 9901 | €92k |
| Financial charges | 65 | €3k |
| Result before taxes | 9903 | €89k |
| Income taxes | 67/77 | €18k |
| Net result for the period | 9904 | €71k |
| Result to be appropriated | 9905 | €71k |
Legal Structure
| NACE primary | Retail sale of pharmaceutical products(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 10-10-2023 |
| Status | Active |
| Postal code | 4122 |
Establishment units
GPHARMA
since 20232.350.983.456
Real-estate footprint
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62081B0079/00T000 | Wallonia | 2,809 m² | 1 · 307 m² | 8.5 m · 2 fl. |
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates
2025
25-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
NBB filing
Belgian State Gazette reading coverage
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Credit advice
Company registry (CBE)
Activities
Retail sale of pharmaceutical products47730Office administrative and support services82100Office administrative, office support and other business support activities82110Organisation of conventions and trade shows82300Other business support services82990Other education85599
Names & trade names
| Legal nameFR | GPHARMA |
Similar companies
PHARMACIE EVRARD - NORTIER
BE 0464.369.880 · Charleroi
PHARMACIE VANHEES
BE 0506.907.647 · Vorst
ELAPHARMA
BE 0785.990.208 · Brussel
APOTHEEK NEVEJAN
BE 0786.445.811 · De Panne
FARMA V.T.B.
BE 0446.285.023 · Oud-Turnhout